Advertisement

Organs, embryos, and part-human chimeras: further applications of the social account of dignity

  • Julian Koplin
Commentary to
  • 10 Downloads

Abstract

In their recent paper in this journal, Zümrüt Alpinar-Şencan and colleagues review existing dignity-based objections to organ markets and outline a new form of dignity-based objection they believe has more merit: one grounded in a social account of dignity. This commentary clarifies some aspects of the social account of dignity and then shows how this revised account can be applied to other perennial issues in bioethics, including the ethics of human embryo research and the ethics of creating part-human chimeras.

Keywords

Human dignity Organ transplantation Commodification Embryo research Part-human chimeras 

References

  1. Alpinar-Şencan, Z., H. Baumann, and N. Biller-Andorno. 2017. Does organ selling violate human dignity? Monash Bioethics Review 34 (3–4): 189–205.CrossRefGoogle Scholar
  2. Baylis, F., and J.S. Robert. 2007. Part-human chimeras: Worrying the facts, probing the ethics. The American Journal of Bioethics 7 (5): 41–45.CrossRefGoogle Scholar
  3. Bekoff, M., and J. Pierce. 2009. Wild justice: The moral lives of animals. Chicago: University of Chicago Press.CrossRefGoogle Scholar
  4. Bortolotti, L., and J. Harris. 2006. Embryos and eagles: Symbolic value in research and reproduction. Cambridge Quarterly of Healthcare Ethics 15 (1): 22–34.CrossRefGoogle Scholar
  5. Chan, S. 2017. How to rethink the fourteen-day rule. Hastings Center Report 47 (3): 5–6.CrossRefGoogle Scholar
  6. Cohen, C.B. 2002. Public policy and the sale of human organs. Kennedy Institute of Ethics Journal 12 (1): 47–64.CrossRefGoogle Scholar
  7. DeGrazia, D. 1997. Great apes, dolphins, and the concept of personhood. The Southern Journal of Philosophy 35 (3): 301–320.CrossRefGoogle Scholar
  8. DeGrazia, D. 2007. Human-animal chimeras: Human dignity, moral status, and species prejudice. Metaphilosophy 38 (2–3): 309–329.  https://doi.org/10.1111/j.1467-9973.2007.00476.x.CrossRefGoogle Scholar
  9. Foster, C. 2014. Dignity and the ownership and use of body parts. Cambridge Quarterly of Healthcare Ethics 23 (4): 417–430.CrossRefGoogle Scholar
  10. Harris, J. 1998. Cloning and human dignity. Cambridge Quarterly of Healthcare Ethics 7 (2): 163–167.CrossRefGoogle Scholar
  11. Hyun, I., A. Wilkerson, and J. Johnston. 2016. Embryology policy: Revisit the 14-day rule. Nature 533: 169–171.CrossRefGoogle Scholar
  12. Karpowicz, P., C.B. Cohen, and D. Van der Kooy. 2005. Developing human–nonhuman chimeras in human stem cell research: Ethical issues and boundaries. CHIMBRIDS 1: 535–555.Google Scholar
  13. Kass, L.R. 1992. Organs for sale? Propriety, property, and the price of progress. Public Interest 107: 65.Google Scholar
  14. Kerstein, S.J. 2009. Kantian condemnation of commerce in organs. Kennedy Institute of Ethics Journal 19 (2): 147–169.CrossRefGoogle Scholar
  15. Koplin, J.J. 2014. Assessing the likely harms to kidney vendors in regulated organ markets. The American Journal of Bioethics 14 (10): 7–18.CrossRefGoogle Scholar
  16. Koplin, J.J. 2017. Beyond fair benefits: Reconsidering exploitation arguments against organ markets. Health Care Analysis.  https://doi.org/10.1007/s10728-017-0340-z.CrossRefGoogle Scholar
  17. Macklin, R. 2003. Dignity is a useless concept. British Medical Journal Publishing Group..  https://doi.org/10.1136/bmj.327.7429.1419.CrossRefGoogle Scholar
  18. Morelli, M. 1999. Commerce in organs: A Kantian critique. Journal of Social Philosophy 30 (2): 315–324.CrossRefGoogle Scholar
  19. Muders, S. 2017. Human dignity in bioethics. Encyclopedia of Life Sciences.Google Scholar
  20. Nicol, C. 2013. Do elephants have souls? The New Atlantis: A Journal of Technology & Society 38: 10–70.Google Scholar
  21. Resnik, D.B. 2007. Embryonic stem cell patents and human dignity. Health Care Analysis 15 (3): 211–222.CrossRefGoogle Scholar
  22. Robert, J.S., and F. Baylis. 2003. Crossing species boundaries. American Journal of Bioethics 3 (3): 1–13.CrossRefGoogle Scholar
  23. Robertson, J.A. 1995. Symbolic issues in embyro research. The Hastings Center Report 25 (1): 37.CrossRefGoogle Scholar
  24. Sandel, M.J. 2004. Embryo ethics-the moral logic of stem-cell research. The New England Journal of Medicine. 351: 207–209.CrossRefGoogle Scholar
  25. Scheper-Hughes, N. 2003. Keeping an eye on the global traffic in human organs. The Lancet 361 (9369): 1645–1648.CrossRefGoogle Scholar
  26. Schüklenk, U., and A. Pacholczyk. 2010. Dignity’s wooly uplift. Bioethics 24 (2): ii.CrossRefGoogle Scholar
  27. Shapiro, P. 2006. Moral agency in other animals. Theoretical Medicine and Bioethics 27 (4): 357–373.CrossRefGoogle Scholar
  28. Steinbock, B. 2001. Respect for human embryos. Cloning and the Future of Human Embryo Research 21–33.Google Scholar
  29. Streiffer, R. 2005. At the edge of humanity: Human stem cells, chimeras, and moral status. Kennedy Institute of Ethics Journal 15 (4): 347–370.CrossRefGoogle Scholar
  30. Tonkens, R. 2018. Effective altruists ought to be allowed to sell their kidneys. Bioethics. 32: 147–154.CrossRefGoogle Scholar
  31. Wu, J., A. Platero-Luengo, M. Sakurai, A. Sugawara, M.A. Gil, T. Yamauchi, et al. 2017. Interspecies chimerism with mammalian pluripotent stem cells. Cell 168 (3): 473–486.  https://doi.org/10.1016/j.cell.2016.12.036.CrossRefGoogle Scholar

Copyright information

© Monash University 2018

Authors and Affiliations

  1. 1.Melbourne Law SchoolThe University of MelbourneParkvilleAustralia
  2. 2.Murdoch Children’s Research InstituteParkvilleAustralia

Personalised recommendations